• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    V

    Vinayaka Missions University

    院校EST. 1981
    819论文总数
    5,110引用总数

    Vinayaka Mission's Research Foundation is a UGC, Government of India recognized private deemed-to-be-university located in Salem, Tamil Nadu, India. In 2015, the University was accredited by National Assessment and Accreditation Council.

    论文量&引用量时间轴

    机构学者

    论文(821)

    年份
    起
    –
    止
    排序
    1Optimization of Mechanical Performance of Underwater Friction Stir Welded AA5754 Aluminum Alloy Using MEREC–CoCoSo Approach
    Ganesh Babu L., Asha G. R., Gomathi M., Venkata Veeranjaneyulu I., Vetrivel K. P., Vinod Kumar D.

    Underwater Friction Stir Welding has arisen as proficient solid-state joining method for aluminium alloys necessitating stringent heat regulation. This work experimentally tested and systematically optimized the mechanical performance of 5 mm thick AA5754 butt joints produced by Underwater Friction Stir Welding. The influence of tool rotational speed, axial force and welding speed, on microhardness and tensile strength was assessed by an experimental design based on Taguchi orthogonal array. ANOVA were utilized to assess significance and impact of each process parameter. A multi-criteria decision-making (MCDM) MEREC and CoCoSo approaches was employed to determine best parameter combination, thereby addressing constraints of traditional single-response optimization. The findings indicate that tool rotational speed is the predominant contributor, succeeded by axial force and welding speed. Ideal process parameters for enhanced ki was determined at a a tool rotation speed of 1100 rpm, an axial force of 6 kN, and welding speed of 20 mm/min, corresponding to (X2 Y2 Z2). The enhanced UFSW condition led to a significant enhancement in joint efficiency and tensile strength, achieving approximately 90

    2026Interactions(2026)引用:23
    引用
    AI阅读
    加入学术空间
    2Mechanical and Moisture Absorption Performance of Tamarind Seed Shell Powder Reinforced Waru Bark–banana Pseudo Stem Fiber Composites
    Shailendra Kumar Yadav, J Srinivas, B Velliyangiri, S Balamurugan, N Shalom, D Vinod Kumar

    The utilization of fiber-reinforced composite materials is increasingly prevalent in the aerospace, structural and automotive industries, owing to lightweight characteristics. This research evaluates tamarind seed shell powder (TSSP) reinforced Waru bark-Banana pseudostem (WBBP) fiber composites, fabricated using compression molding. TSSP was incorporated at weight ratios of 0, 2, 4, 6, and 8 wt

    2026Interactions(2026)引用:10
    引用
    AI阅读
    加入学术空间
    3Revealing CASQ1 As a Potential Target for Oral Squamous Cell Carcinoma Through Gene Expression and Functional Analysis: an in Silico Approach
    Yamuna Annadurai,Murugesh Easwaran,Sriram Kaliamoorthy

    Oral squamous cell carcinoma (OSCC) is a significant global health concern, with approximately 377,000 new cases diagnosed annually worldwide. Despite advances in treatment, OSCC remains a leading cause of cancer-related morbidity and mortality, particularly in regions with high prevalence such as Asia and Oceania. In order to identify potential drug targets for OSCC, this study employed an integrative in silico pharmacology strategy. Nineteen GEO transcriptomic datasets (435 samples) were analyzed, 580 significantly overexpressed genes (logFC > 2.5). Network and enrichment analyses highlighted CASQ1 (calsequestrin 1), a calcium-binding protein, as a hub gene within a sarcomeric cluster implicated in epithelial–mesenchymal transition and OSCC progression. To explore its therapeutic potential, molecular docking and 500 ns molecular dynamics (MD) simulations were performed with standard chemotherapeutics, 5-fluorouracil and docetaxel. 5-fluorouracil exhibited strong binding affinity (− 7.225 kcal/mol) and stable conformational dynamics with CASQ1, while docetaxel showed more flexible but persistent binding. These results suggest that CASQ1 is a previously unrecognized drug-interactable target in OSCC and may represent a novel pharmacological vulnerability. Overall, this study demonstrates how integrative computational approaches, spanning gene expression profiling to drug–target interaction modeling, can accelerate target discovery and inform therapeutic strategies in oncology.

    2026In Silico Pharmacology(2026)
    引用
    AI阅读
    加入学术空间
    4Autologous CD133 + Cell Therapy During Coronary Artery Bypass Grafting for Ischemic Cardiomyopathy: Systematic Review and Meta-Analysis
    Brenda Cunningham,Alejandro Antonio Merazo Valle,Valentyna Ochoa Castro, Tridisha Chowdhury, Andres Toledo, Ayleen Gonzalez, Jonathan Reyes, Stephani Carolina Salvatierra Moreno, Kaodichimma Fidelugwuowo, Andrew Krishock, Sabrina Domene, Ernesto Calderon Martinez

    Background: Ischemic cardiomyopathy remains a leading cause of cardiovascular mortality. Autologous CD133 + therapy has emerged as a promising alternative for ischemic cardiomyopathy in patients undergoing coronary artery bypass grafting (CABG). However, evidence regarding its safety and clinical efficacy remains limited, restricting the ability to clearly define its therapeutic role in ischemic cardiomyopathy. This uncertainty underscores the need for a systematic evaluation of the available evidence. Therefore, this systematic review and meta-analysis aimed to evaluate the clinical efficacy and safety of adjunctive CD133 + stem cell therapy administered during CABG. Methods: A comprehensive search of PubMed, Embase, Web of Science, Scopus, Google Scholar, and Cochrane databases was conducted from inception to January 2026. Eligible studies included English-language randomized controlled trials (RCTs) and observational studies involving adults (≥18 years) with ischemic cardiomyopathy undergoing CABG in whom intraoperative administration of autologous CD133 + cells plus CABG was compared with CABG alone. Results: 11 studies and 495 participants were included in the analysis. Compared with coronary artery bypass grafting (CABG) alone, adjunctive CD133 + cell therapy was not associated with significant differences in magnetic resonance imaging (MRI)-derived left ventricular ejection fraction (LVEF) (n=144; mean difference [MD], 0.40 [95% CI, –5.60 to 6.41]; p=0.89; I 2 =72.9%), MRI-assessed myocardial scar burden (n=86; MD, –1.94 [95% CI, –8.17 to 4.28]; p=0.54; I 2 =0%), or ultrasound-derived LVEF (n=278; MD, 0.45 [95% CI, –2.24 to 3.14]; p=0.74; I 2 =45.3%). No significant differences were observed in arrhythmia (n=118; relative risk [RR], 1.00 [95% CI, 0.85-1.19]; p=0.87; I 2 =0%) or mortality (n=114; RR, 1.31 [95% CI, 0.06-27.03]; p=0.46; I 2 =0%). Hospital length of stay was longer in the CD133 + group (n=95; MD, 2.00 days [95% CI, 0.98-3.02]; p=0.0001; I 2 =0%). Conclusion: Adjunctive CD133 + cell therapy during CABG was not associated with significant improvements in ventricular function, myocardial scar burden, arrhythmia, or mortality compared with CABG alone. Further studies are needed to better define its role in selected patient populations.

    2026Circulation(2026)
    引用
    AI阅读
    加入学术空间
    5Autologous CD133⁺ Progenitor Cell Therapy As an Adjunct to Coronary Artery Bypass Grafting in Ischemic Cardiomyopathy: a Systematic Review and Meta-Analysis
    Brenda Cunningham,Alejandro Antonio Merazo Valle,Valentyna Ochoa Castro, Tridisha Chowdhury, Andres Toledo, Ayleen Aurora Gonzalez Pilier, Jonathan Reyes,Stephani Carolina Salvatierra Moreno, Kaodichimma Dickson Fidelugwuowo, Andrew Krishock, Sabrina Soledad Domene, Daniel Camilo Agudelo Restrepo,

    Ischemic cardiomyopathy remains a leading cause of cardiovascular mortality. Although autologous CD133⁺ progenitor cell therapy has been investigated as an adjunct to coronary artery bypass grafting (CABG), its clinical efficacy and safety remain uncertain. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of autologous CD133⁺ cell therapy administered during CABG in patients with ischemic cardiomyopathy. A comprehensive search of PubMed/MEDLINE, Embase, Web of Science, Scopus, Google Scholar, and the Cochrane Library was conducted from database inception to January 2026. Eligible studies included randomized controlled trials and observational studies involving adults with ischemic cardiomyopathy in whom intraoperative administration of autologous CD133⁺ cells during CABG was compared with CABG alone. Random-effects meta-analyses were performed using maximum likelihood estimation with Hartung-Knapp adjustment. The certainty of evidence for critical and important outcomes was assessed using GRADE. Eleven studies encompassing 495 participants were included (7 RCTs, 4 cohort studies). No significant between-group difference was observed in MRI-assessed LVEF (MD − 1.34

    2026BMC Cardiovascular Disorders(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 821 篇论文

    合作机构(100)

    巴拉蒂亚尔大学合作论文 12
    Vinayaka Missions Medical College and Hospitals合作论文 11
    Saveetha University合作论文 10
    Sathyabama Institute of Science and Technology合作论文 10
    SRM Institute of Science and Technology合作论文 9
    Saveetha Institute of Medical And Technical Sciences合作论文 8
    Annamalai University合作论文 8
    Aarupadai Veedu Medical College & Hospital合作论文 8
    沙特国王大学合作论文 7
    Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology合作论文 7

    机构统计